Results of isoproterenol tilt table testing in monozygotic twins discordant for chronic fatigue syndrome.
Poole, J, Herrell, R, Ashton, S et al. · Archives of internal medicine · 2000 · DOI
Quick Summary
This study tested whether a condition called neurally mediated hypotension (a sudden drop in blood pressure) might be causing ME/CFS. Researchers compared identical twins where one had ME/CFS and one was healthy, using a tilt table test to measure blood pressure responses. They found that healthy twins and twins with ME/CFS had similar rates of this blood pressure problem, suggesting it is probably not a main cause of ME/CFS.
Why It Matters
This study challenges the hypothesis that neurally mediated hypotension is a primary driver of ME/CFS, an idea that had gained clinical traction in the 1990s. By using genetically identical twins and rigorous matching, it provides strong evidence that factors other than NMH abnormalities must underlie ME/CFS pathogenesis, redirecting research focus toward other biological mechanisms.
Observed Findings
Positive tilt table test results were observed in 4 of 21 twins with CFS (19%)
Positive tilt table test results were observed in 4 of 21 healthy cotwin controls (19%)
CFS-affected twins reported more severe CFS and NMH symptoms in the week before and during testing compared to healthy cotwin controls
The matched pair odds ratio for NMH was 1.0 (95% CI 0.2–5.4) with P>0.90, indicating no statistical difference
All participants completed a 3-stage isoproterenol tilt table test as part of a comprehensive 7-day clinical evaluation
Inferred Conclusions
Neurally mediated hypotension does not play a major role in the pathogenesis of ME/CFS
Monozygotic cotwin control studies are valuable for distinguishing genetic from environmental factors in ME/CFS
Subjective symptom severity in ME/CFS does not correlate with objective NMH abnormalities measured by tilt table testing
Other biological mechanisms beyond NMH must be investigated as potential causes of ME/CFS
Remaining Questions
What other autonomic nervous system or cardiovascular abnormalities might explain the symptom differences reported by CFS-affected twins during tilt testing?
What This Study Does Not Prove
This study does not prove that NMH never occurs in ME/CFS patients or that it cannot contribute to symptoms in a subset of patients. The finding of equal NMH prevalence in both groups does not rule out other cardiovascular or autonomic nervous system abnormalities in ME/CFS. Additionally, the study cannot explain why CFS-affected twins reported more severe symptoms during testing despite similar objective test results.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Why do CFS-affected twins perceive and report more severe symptoms despite similar objective test results compared to healthy cotwins?
What is the role of other potential pathogenic mechanisms (immune dysfunction, mitochondrial dysfunction, post-exertional malaise) in ME/CFS that were not assessed in this study?
Does the discrepancy between subjective and objective findings in CFS-affected twins indicate a difference in symptom perception, central sensitization, or other psychological/neurobiological factors?